SCHEMBL25243117

SCHEMBL25243117

Cc1c(S)ccc(C(=O)CC(C)(C)C)c1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30506530 0.83 MEN1 (0.54) —
SCHEMBL4946050 0.83 MEN1 (0.54) —
SCHEMBL25288911 0.80 GRM2 (0.44) —
SCHEMBL28641776 0.74 GRM1 (0.51) —
SCHEMBL30506565 0.73 — —
SCHEMBL18428640 0.73 — —
SCHEMBL25288608 0.73 — —
SCHEMBL12231322 0.71 GRM2 (0.38) —
SCHEMBL6471909 0.71 ALDH1A1 (0.40) —
SCHEMBL25288653 0.69 GRM2 (0.56) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250179000-A1 METABOTROPIC GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATORS (PAMS) AND USES THEREOF Sanford Burnham Prebys Medical Discovery Institute 2025-06-05 — — US disclosed
EP-4452918-A1 METABOTROPIC GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATORS (PAMS) AND USES THEREOF Sanford Burnham Prebys Medical Discovery Institute (US) 2024-10-30 — — EP disclosed
WO-2023122276-A1 METABOTROPIC GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATORS (PAMS) AND USES THEREOF Sanford Burnham Prebys Medical Discovery Institute (US) 2023-06-29 — — WO disclosed
Send feedback